Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.

MLA

Sama, Iziah E., et al. “Circulating Plasma Concentrations of Angiotensin-Converting Enzyme 2 in Men and Women with Heart Failure and Effects of Renin-Angiotensin-Aldosterone Inhibitors.” European Heart Journal, vol. 41, no. 19, May 2020, pp. 1810–17. EBSCOhost, https://doi.org/10.1093/eurheartj/ehaa373.

APA

Sama, I. E., Ravera, A., Santema, B. T., van Goor, H., Ter Maaten, J. M., Cleland, J. G. F., Rienstra, M., Friedrich, A. W., Samani, N. J., Ng, L. L., Dickstein, K., Lang, C. C., Filippatos, G., Anker, S. D., Ponikowski, P., Metra, M., van Veldhuisen, D. J., & Voors, A. A. (2020). Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. European Heart Journal, 41(19), 1810–1817. https://doi.org/10.1093/eurheartj/ehaa373

Chicago

Sama, Iziah E, Alice Ravera, Bernadet T Santema, Harry van Goor, Jozine M Ter Maaten, John G F Cleland, Michiel Rienstra, et al. 2020. “Circulating Plasma Concentrations of Angiotensin-Converting Enzyme 2 in Men and Women with Heart Failure and Effects of Renin-Angiotensin-Aldosterone Inhibitors.” European Heart Journal 41 (19): 1810–17. doi:10.1093/eurheartj/ehaa373.